Financial Performance - Alpha Cognition Inc. reported a quarterly loss of $0.20 per share, significantly better than the Zacks Consensus Estimate of a loss of $0.58, and an improvement from a loss of $0.75 per share a year ago, representing an earnings surprise of 65.52% [1] - The company posted revenues of $2.93 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 26.78%, compared to zero revenues a year ago [2] Stock Performance - Alpha Cognition Inc. shares have increased approximately 16.5% since the beginning of the year, outperforming the S&P 500's gain of 0.2% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.84 on revenues of $0.96 million, and for the current fiscal year, it is -$2.93 on revenues of $10.03 million [7] - The estimate revisions trend for Alpha Cognition Inc. is currently unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Medical - Biomedical and Genetics industry, to which Alpha Cognition Inc. belongs, is currently in the top 28% of over 250 Zacks industries, suggesting a favorable industry outlook [8]
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Misses Revenue Estimates